OQS
FBRX icon

Occudo Quantitative Strategies’s Forte Biosciences FBRX Stock Holding History

Occudo Quantitative Strategies’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,632
Closed -$417K – 1119
2021
Q3 		$417K Buy
+5,632
New +$3.12M 0.05% 611

Other funds holding FBRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Occudo Quantitative Strategies's FBRX Position: Q4 2021 in Review

Occudo Quantitative Strategies sold out of Forte Biosciences (FBRX) in Q4 2021, closing a stake of 5,632 shares — an estimated $417K sold.

Occudo Quantitative Strategies first reported a position in FBRX in Q3 2021 and held it in 1 quarter. The position peaked at $417K in Q3 2021. 52 funds tracked by Wall St. Rank hold FBRX as of Q4 2021.

  • Occudo Quantitative Strategies reported no remaining Forte Biosciences position as of Q4 2021 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 5,632 Forte Biosciences shares in Q4 2021, an estimated $417K.
  • Occudo Quantitative Strategies first reported a position in Forte Biosciences in Q3 2021 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Forte Biosciences position peaked at $417K in Q3 2021.
  • 52 funds tracked by Wall St. Rank held Forte Biosciences as of Q4 2021.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.